Homocysteic acid as transmitter candidate in the mammalian brain and excitatory amino acids in epilepsy. 1990

M Cuénod, and E Audinat, and K Q Do, and B H Gähwiler, and P Grandes, and P Herrling, and T Knöpfel, and H Perschak, and P Streit, and F Vollenweider
Brain Research Institute, Zürich University, Switzerland.

UI MeSH Term Description Entries
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006710 Homocysteine A thiol-containing amino acid formed by a demethylation of METHIONINE. 2-amino-4-mercaptobutyric acid,Homocysteine, L-Isomer,2 amino 4 mercaptobutyric acid,Homocysteine, L Isomer,L-Isomer Homocysteine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016194 Receptors, N-Methyl-D-Aspartate A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity. N-Methyl-D-Aspartate Receptor,N-Methyl-D-Aspartate Receptors,NMDA Receptor,NMDA Receptor-Ionophore Complex,NMDA Receptors,Receptors, NMDA,N-Methylaspartate Receptors,Receptors, N-Methylaspartate,N Methyl D Aspartate Receptor,N Methyl D Aspartate Receptors,N Methylaspartate Receptors,NMDA Receptor Ionophore Complex,Receptor, N-Methyl-D-Aspartate,Receptor, NMDA,Receptors, N Methyl D Aspartate,Receptors, N Methylaspartate
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

M Cuénod, and E Audinat, and K Q Do, and B H Gähwiler, and P Grandes, and P Herrling, and T Knöpfel, and H Perschak, and P Streit, and F Vollenweider
December 1990, Trends in pharmacological sciences,
M Cuénod, and E Audinat, and K Q Do, and B H Gähwiler, and P Grandes, and P Herrling, and T Knöpfel, and H Perschak, and P Streit, and F Vollenweider
January 1990, Progress in neurobiology,
M Cuénod, and E Audinat, and K Q Do, and B H Gähwiler, and P Grandes, and P Herrling, and T Knöpfel, and H Perschak, and P Streit, and F Vollenweider
January 1998, Restorative neurology and neuroscience,
M Cuénod, and E Audinat, and K Q Do, and B H Gähwiler, and P Grandes, and P Herrling, and T Knöpfel, and H Perschak, and P Streit, and F Vollenweider
December 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
M Cuénod, and E Audinat, and K Q Do, and B H Gähwiler, and P Grandes, and P Herrling, and T Knöpfel, and H Perschak, and P Streit, and F Vollenweider
January 1989, Neurochemistry international,
M Cuénod, and E Audinat, and K Q Do, and B H Gähwiler, and P Grandes, and P Herrling, and T Knöpfel, and H Perschak, and P Streit, and F Vollenweider
March 1991, Proceedings of the National Academy of Sciences of the United States of America,
M Cuénod, and E Audinat, and K Q Do, and B H Gähwiler, and P Grandes, and P Herrling, and T Knöpfel, and H Perschak, and P Streit, and F Vollenweider
February 1993, Biochemical Society transactions,
M Cuénod, and E Audinat, and K Q Do, and B H Gähwiler, and P Grandes, and P Herrling, and T Knöpfel, and H Perschak, and P Streit, and F Vollenweider
August 1993, Current opinion in neurology and neurosurgery,
M Cuénod, and E Audinat, and K Q Do, and B H Gähwiler, and P Grandes, and P Herrling, and T Knöpfel, and H Perschak, and P Streit, and F Vollenweider
August 1990, Trends in pharmacological sciences,
M Cuénod, and E Audinat, and K Q Do, and B H Gähwiler, and P Grandes, and P Herrling, and T Knöpfel, and H Perschak, and P Streit, and F Vollenweider
January 1991, Epilepsia,
Copied contents to your clipboard!